|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-earning deposits with banks | ||||||||||||||||||||
| Total cash, cash equivalents, and restricted cash | ||||||||||||||||||||
| Federal funds sold and securities purchased under resale agreements | ||||||||||||||||||||
| Trading, at fair value | ||||||||||||||||||||
| Federal funds sold and securities borrowed or purchased under resale agreements | ||||||||||||||||||||
| Trading assets | ||||||||||||||||||||
| Available-for-sale debt securities | ||||||||||||||||||||
| Held-to-maturity debt securities | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Total loans | ||||||||||||||||||||
| Allowance for loan losses | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Mortgage servicing rights | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Derivative assets | ||||||||||||||||||||
| Equity securities, carried at fair value | ||||||||||||||||||||
| Equity securities | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Noninterest-bearing deposits | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Federal funds purchased and securities loaned or sold under repurchase agreements | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Trading liabilities | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Wells Fargo stockholders’ equity: | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Treasury stock, at cost | ||||||||||||||||||||
| Unearned ESOP shares | ||||||||||||||||||||
| Total Wells Fargo stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
